RCEL

Avita Medical Inc. Common Stock (RCEL)

Stock · NASDAQ · Health Care

$10.34as of 8/28/2026

Active signals

High Beta42.2%
Support level
$4.11
Industry
Medical/Dental Instruments

How Avita Medical Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$70.88MSG&A$80.51M (114%)R&D$20.84M (29%)Cost of Revenue$12.79M (18%)Tax$11.0K (0%)RCEL

Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub

Avita Medical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • RCEL
    Avita Medical Inc. Common Stock
    $10.34
    ▲ 0.19%
    Market cap $146.19MP/E
  • STIM
    Neuronetics Inc. Common Stock
    $2.95
    ▼ 0.51%
    Market cap $156.57MP/E
    $0.8$3.8
  • CVRX
    CVRx Inc. Common Stock
    $2.95
    ▼ 3.12%
    Market cap $157.62MP/E
  • KRMD
    KORU Medical Systems Inc. Common Stock (DE)
    $3.24
    ▲ 1.09%
    Market cap $163.52MP/E
    $3.21$6.61
  • MBOT
    Microbot Medical Inc. Common Stock
    $1.48
    ▼ 1.67%
    Market cap $120.90MP/E
    $1.44$4.67
  • APYX
    Apyx Medical Corporation Common Stock
    $3.08
    ▲ 2.67%
    Market cap $174.35MP/E
    $1.7$5.08
  • LUCD
    Lucid Diagnostics Inc. Common Stock
    $0.9989
    ▲ 1.51%
    Market cap $193.54MP/E
    $0.8605$1.63

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
86.89M
Total value held
$214.95M
Institutional holders
75
Top holders this quarter
  • Unknown82.01M
  • Unknown1.34M
  • Unknown1.13M
  • Unknown543.0K
  • Unknown429.0K
  • Unknown183.2K
  • Unknown157.6K
  • Unknown100.0K
  • Unknown99.8K
  • Unknown94.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.